MRKR vs PSX · rev $751.7K vs P/E 17, rev $83.54B
Marker Therapeutics Inc (MRKR) versus Phillips 66 (PSX) — a side-by-side from cached financials, not a winner call.
Marker Therapeutics Inc (MRKR) is a biotechnology company listed on US.
Phillips 66 (PSX) is a oil & gas refining & marketing company listed on NYSE.
Latest reported MRKR revenue for 2026-03-31 was $751.7K. Net income was -$3.2M. Revenue was down 69.2% from 2025-09-30 to 2026-03-31. MRKR currently screens at market cap $25.3M.
Latest reported PSX revenue for 2026-06-30 was $83.54B. Net income was $4.05B. PSX currently screens at market cap $67.02B and trailing P/E 16.5.
MRKR currently screens at market cap $25.3M. PSX currently screens at market cap $67.02B and trailing P/E 16.5.
Not investment advice. Open the MRKR and PSX stock pages for the full models.
Not investment advice.